Single User License
INR 168725
Site License
INR 337450
Corporate User License
INR 506175

Service Tax Additional

select a format
Price

Single User License
USD 2500
Site License
USD 5000
Corporate User License
USD 7500

Alternatively

Request a quote
Request a Customized research
Request for Sample Report





Recent Viewed Reports


Why Ken Reasearch?


Testimonials

While we still are studying and analysing your reports about Vietnam & Thailand, we would like to convey to your research team that they have done a very good job in compiling so much of information together. We hope to see more of such well researched reports. All the best & keep it up. ... "Prashant Bhagwat,General Manager, Mahindra"

We would like to appreciate Ken Research for their great efforts and wonderful support in providing the Market Intelligence Report for ITPC. The information, statistics and research are well understandable and very clear to the point. We are happy with Ken research for their good client service, on-time delivery of the report and as said the report itself. Thank you Ken research for bringing the valuable output for us. We would be looking forward to have more research with you in the near future. Wish you a success in your business!... "Jestin Mathew, Indonesian Trade Promotion Center"

The Report was very interesting and useful for me... "Marketing Manager, Western Union Business Solutions"

Ken Research completed the report successfully with tough deadline and large requirement. Really appreciate it... "Sales Manager, Largest India Aesthetic Laser Manufacturer"

We found the report really useful in understanding the complex Indian market and it provided lots of high quality insights. On the basis of this we commissioned Ken to produce a bespoke follow up to answer some specific questions about our market. This is now being used to help develop our marketing and sales strategy. We were very pleased with the comprehensive coverage, detail provided and actionable insights.... "Owner, Therefore Consulting UK"


Candidiasis Global Clinical Trials Review, H1

Candidiasis Global Clinical Trials Review, H1


  Request for Sample Report

Executive Summary

Candidiasis Global Clinical Trials Review, H1, 2015

GlobalData's clinical trial report, "Candidiasis Global Clinical Trials Review, H1, 2015" provides an overview of Candidiasis clinical trials scenario. This report provides top line data relating to the clinical trials on Candidiasis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). Global Data Clinical Trial Reports are generated using Global Data's proprietary database-Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

The report provides a snapshot of the global clinical trials landscape

Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status

The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company

The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment

The Report provides enrollment trends for the past five years

Report provides latest news for the past three months

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons To Buy

Assists in formulating key business strategies with regards to investment

Helps in identifying prominent locations for conducting clinical trials which saves time and cost

Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities

Supports understanding of trials count and enrollment trends by country in global therapeutics market

Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials

Facilitates clinical trial assessment of the indication on a global, regional and country level

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Table of Contents

Table of Contents 2

List of Tables 4

List of Figures 5

Introduction 6

Candidiasis 6

Report Guidance 6

Clinical Trials by Region 7

Clinical Trials and Average Enrollment by Country 8

Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10

Top Five Countries Contributing to Clinical Trials in Europe 11

Top Countries Contributing to Clinical Trials in North America 12

Top Five Countries Contributing to Clinical Trials in Middle East and Africa 13

Top Five Countries Contributing to Clinical Trials in Central and South America 14

Clinical Trials by G7 Countries: Proportion of Candidiasis to Infectious Disease Clinical Trials 15

Clinical Trials by Phase in G7 Countries 16

Clinical Trials in G7 Countries by Trial Status 17

Clinical Trials by E7 Countries: Proportion of Candidiasis to Infectious Disease Clinical Trials 18

Clinical Trials by Phase in E7 Countries 19

Clinical Trials in E7 Countries by Trial Status 20

Clinical Trials by Phase 21

In Progress Trials by Phase 22

Clinical Trials by Trial Status 23

Clinical Trials by End Point Status 24

Unaccomplished Trials of Candidiasis 25

Subjects Recruited Over a Period of Time 29

Clinical Trials by Sponsor Type 30

Prominent Sponsors 31

Top Companies Participating in Candidiasis Therapeutics Clinical Trials 32

Prominent Drugs 33

Clinical Trial Profiles 34

Clinical Trial Overview of Top Companies 34

Pfizer Inc. 34

Clinical Trial Overview of Pfizer Inc. 34

Astellas Pharma Inc. 37

Clinical Trial Overview of Astellas Pharma Inc. 37

Merck & Co., Inc. 39

Clinical Trial Overview of Merck & Co., Inc. 39

Basilea Pharmaceutica AG 41

Clinical Trial Overview of Basilea Pharmaceutica AG 41

Johnson & Johnson 42

Clinical Trial Overview of Johnson & Johnson 42

Bayer AG 43

Clinical Trial Overview of Bayer AG 43

Laboratory Corporation of America Holdings 44

Clinical Trial Overview of Laboratory Corporation of America Holdings 44

GlaxoSmithKline Plc 45

Clinical Trial Overview of GlaxoSmithKline Plc 45

Durata Therapeutics, Inc. 46

Clinical Trial Overview of Durata Therapeutics, Inc. 46

Bristol-Myers Squibb Company 47

Clinical Trial Overview of Bristol-Myers Squibb Company 47

Clinical Trial Overview of Top Institutes / Government 48

The National Institute of Allergy and Infectious Diseases 48

Clinical Trial Overview of The National Institute of Allergy and Infectious Diseases 48

National Cancer Institute 49

Clinical Trial Overview of National Cancer Institute 49

Duke University 50

Clinical Trial Overview of Duke University 50

University Medical Center Groningen 51

Clinical Trial Overview of University Medical Center Groningen 51

Ahvaz Jundishapur University of Medical Sciences 52

Clinical Trial Overview of Ahvaz Jundishapur University of Medical Sciences 52

Indian Council of Medical Research 53

Clinical Trial Overview of Indian Council of Medical Research 53

Shahid Beheshti University 54

Clinical Trial Overview of Shahid Beheshti University 54

Shiraz University of Medical Sciences 55

Clinical Trial Overview of Shiraz University of Medical Sciences 55

Tehran University of Medical Sciences 56

Clinical Trial Overview of Tehran University of Medical Sciences 56

The University of Melbourne 57

Clinical Trial Overview of The University of Melbourne 57

Five Key Clinical Profiles 58

Appendix 98

Abbreviations 98

Definitions 98

Research Methodology 99

Secondary Research 99

About GlobalData 100

Contact Us 100

Disclaimer 100

Source 101

List of Figures

Candidiasis Therapeutics, Global, Clinical Trials by Region (%), 2015* 7

Candidiasis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8

Candidiasis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9

Candidiasis Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2015* 10

Candidiasis Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2015* 11

Candidiasis Therapeutics Clinical Trials, North America, Top Countries (%), 2015* 12

Candidiasis Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2015* 13

Candidiasis Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2015* 14

Proportion of Candidiasis to Infectious Disease Clinical Trials, G7 Countries (%), 2015* 15

Candidiasis Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 16

Candidiasis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 17

Proportion of Candidiasis to Infectious Disease Clinical Trials, E7 Countries (%), 2015* 18

Candidiasis Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 19

Candidiasis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 20

Candidiasis Therapeutics, Global, Clinical Trials by Phase (%), 2015* 21

Candidiasis Therapeutics, Global, Clinical Trials In Progress by Phase, 2015* 22

Candidiasis Therapeutics, Global, Clinical Trials by Trial Status, 2015* 23

Candidiasis Therapeutics Clinical Trials, Global, by End Point Status, 2015* 24

Candidiasis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 29

Candidiasis Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015* 30

Candidiasis Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 31

Candidiasis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 32

Candidiasis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 33

GlobalData Methodology 99

List of Tables

Candidiasis Therapeutics, Global, Clinical Trials by Region, 2015* 7

Candidiasis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8

Candidiasis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9

Candidiasis Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2015* 10

Candidiasis Therapeutics Clinical Trials, Europe, Top Five Countries, 2015* 11

Candidiasis Therapeutics Clinical Trials, North America, Top Countries, 2015* 12

Candidiasis Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2015* 13

Candidiasis Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2015* 14

Proportion of Candidiasis to Infectious Disease Clinical Trials, G7 Countries (%), 2015* 15

Candidiasis Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 16

Candidiasis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 17

Proportion of Candidiasis to Infectious Disease Clinical Trials, E7 Countries (%), 2015* 18

Candidiasis Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 19

Candidiasis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 20

Candidiasis Therapeutics, Global, Clinical Trials by Phase, 2015* 21

Candidiasis Therapeutics, Global, Clinical Trials In Progress by Phase 2015* 22

Candidiasis Therapeutics, Global, Clinical Trials by Trial Status, 2015* 23

Candidiasis Therapeutics Clinical Trials, Global, by End Point Status, 2015* 24

Candidiasis Therapeutics, Global, Suspended Clinical Trials, 2015* 25

Candidiasis Therapeutics, Global, Withdrawn Clinical Trials, 2015* 26

Candidiasis Therapeutics, Global, Terminated Clinical Trials, 2015* 27

Candidiasis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 29

Candidiasis Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015* 30

Candidiasis Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 31

Candidiasis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 32

Candidiasis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 33

Candidiasis Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2015* 34

Candidiasis Therapeutics Clinical Trials Market, Global, Clinical Trials by Astellas Pharma Inc., 2015* 37

Candidiasis Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck & Co., Inc., 2015* 39

Candidiasis Therapeutics Clinical Trials Market, Global, Clinical Trials by Basilea Pharmaceutica AG, 2015* 41

Candidiasis Therapeutics Clinical Trials Market, Global, Clinical Trials by Johnson & Johnson, 2015* 42

Candidiasis Therapeutics Clinical Trials Market, Global, Clinical Trials by Bayer AG, 2015* 43

Candidiasis Therapeutics Clinical Trials Market, Global, Clinical Trials by Laboratory Corporation of America Holdings, 2015* 44

Candidiasis Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline Plc, 2015* 45

Candidiasis Therapeutics Clinical Trials Market, Global, Clinical Trials by Durata Therapeutics, Inc., 2015* 46

Candidiasis Therapeutics Clinical Trials Market, Global, Clinical Trials by Bristol-Myers Squibb Company, 2015* 47

Candidiasis Therapeutics Clinical Trials Market, Global, Clinical Trials by The National Institute of Allergy and Infectious Diseases, 2015* 48

Candidiasis Therapeutics Clinical Trials Market, Global, Clinical Trials by National Cancer Institute, 2015* 49

Candidiasis Therapeutics Clinical Trials Market, Global, Clinical Trials by Duke University, 2015* 50

Candidiasis Therapeutics Clinical Trials Market, Global, Clinical Trials by University Medical Center Groningen, 2015* 51

Candidiasis Therapeutics Clinical Trials Market, Global, Clinical Trials by Ahvaz Jundishapur University of Medical Sciences, 2015* 52

Candidiasis Therapeutics Clinical Trials Market, Global, Clinical Trials by Indian Council of Medical Research, 2015* 53

Candidiasis Therapeutics Clinical Trials Market, Global, Clinical Trials by Shahid Beheshti University, 2015* 54

Candidiasis Therapeutics Clinical Trials Market, Global, Clinical Trials by Shiraz University of Medical Sciences, 2015* 55

Candidiasis Therapeutics Clinical Trials Market, Global, Clinical Trials by Tehran University of Medical Sciences, 2015* 56

Candidiasis Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Melbourne, 2015* 57

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to query [@] kenresearch.com
 

Pfizer Inc.

Astellas Pharma Inc.

Merck & Co., Inc.

Basilea Pharmaceutica AG

Johnson & Johnson

Bayer AG

Laboratory Corporation of America Holdings

GlaxoSmithKline Plc

Durata Therapeutics, Inc.

Bristol-Myers Squibb Company

Candidiasis Clinical Trials, Phase, Completed, Ongoing, Planned, End Points, Trial Locations, Trial Designs, Subjects Recruited, Safety, Efficacy, Bioequivalence, Pharmacokinetics, Pharmacodynamic, Sponsor, Collaborator, CRO's, Terminated, Suspended and Withdrawn trials of Candidiasis, Pfizer, AstraZeneca, Novartis, GlaxoSmithKline, Sanofi, Eli Lilly and Company, Johnson & Johnson, Merck & Co., Inc, Bristol-Myers Squibb Company, Abbott Laboratories, Hoffmann-La Roche Ltd., Celgene Corporation, Daiichi Sankyo Company, Ltd., Bayer AG, Eisai Inc., GE Healthcare, Biogen Idec Inc., Copharos Inc., Wyeth Pharmaceuticals Inc., National Cancer Center, The University of Texas M. D. Anderson Cancer Center, Vanderbilt Medical Center, Memorial Sloan Kettering Cancer Center, Cancer Research UK, North Central Cancer Group, Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Fred Hutchinson Cancer Research Center, European Organization for Research and Treatment of Cancer, Dana-Farber Cancer Institute, The Cancer and Leukemia Group B, Columbia University, UCLA's Jonsson Comprehensive Cancer Center, Case Comprehensive Cancer Center, Mayo Clinic, Duke University, Ohio State University, University of Pennsylvania.


Related Products in vertical
Ken Research Pvt. Ltd. 27A, Tower B-2, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India
+91 1244230204

download

Company Brochure

Engage with Us

query [@] kenresearch.com